Odyssey Health (ODYY) FCF Margin (2014 - 2016)

Odyssey Health's (ODYY) quarterly FCF Margin came in at 63.13% in Q3 2016, up 31.13% quarter-over-quarter from 91.66% in Q2 2016.

Odyssey Health (ODYY) FCF Margin (2014 - 2016) Analysis & Trends

Odyssey Health's FCF Margin history runs 3 years deep, the most recent figure standing at 63.13% for Q3 2016.

  • On a quarterly basis, FCF Margin changed N/A year-over-year to 63.13% in Q3 2016; TTM through Apr 2017 was 594.98%, a 36233.0% decrease from a year earlier, with the FY2016 full-year figure at 171.34%, down 24358.0% from the prior year.
  • FCF Margin advanced to 63.13% in Q3 2016 per ODYY's latest filing, from 91.66% in the prior quarter.
  • Across five years, FCF Margin topped out at 87.73% in Q4 2014 and bottomed at 91.66% in Q2 2016.
  • The 3-year median for FCF Margin is 26.77% (2015), against an average of 3.95%.
  • Biggest YoY gain for FCF Margin was 11843 bps in 2016; the steepest drop was 11843 bps in 2016.
  • Year by year, FCF Margin stood at 87.73% in 2014, then plunged by 69 bps to 26.77% in 2015, then plunged by 336 bps to 63.13% in 2016.
  • Per Business Quant, the three latest ODYY FCF Margin figures stand at 63.13% (Q3 2016), 91.66% (Q2 2016), and 26.77% (Q2 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 8.20%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 6.89%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 21.26%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 3.29%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -1.28%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 37.67%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 6.68%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.18%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Odyssey Health 1.08 Mn 782,508.17 - -

Historic Data

Download Data
DateValue
Jul 31, 2016 -63.13%
Apr 30, 2016 -91.66%
Apr 30, 2015 26.77%
Jan 31, 2015 60.06%
Oct 31, 2014 87.73%